(Q27002495)

English

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis (English)

0 references

carbapenem antibiotic

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

Enterobacteriaceae

1 reference

based on heuristic

inferred from title

author name string

K. Z. Vardakas

1

1 reference

G. S. Tansarli

2

1 reference

P. I. Rafailidis

3

1 reference

M. E. Falagas

4

1 reference

language of work or name

1 reference

publication date

December 2012

1 reference

Journal of Antimicrobial Chemotherapy

1 reference

67

1 reference

12

1 reference

2793-803

1 reference

Extended-spectrum beta-lactamase-producing organisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Extended-spectrum beta-lactamases and clinical outcomes: current data

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Mortality rate in neonates infected with extended-spectrum beta lactamase-producing Klebsiella species and selective empirical use of meropenem.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

[Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Piperacillin-tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteraemia in Europe--antimicrobial susceptibility data from the MYSTIC surveillance programme

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bioactive microbial metabolites

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Monte Carlo simulation for evaluation of the efficacy of carbapenems and new quinolones against ESBL-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27002495&oldid=1621843750"